| Literature DB >> 35620095 |
Meghan Maguire1, Anisa S Khan2, Abiodun A Adesiyun2, Karla Georges2, Narjol Gonzalez-Escalona1.
Abstract
Salmonella enterica is an important foodborne pathogen worldwide. We used long and short-read sequencing to close genomes of eight multidrug-resistant (MDR) S. enterica strains, belonging to serovars Infantis (2), Albany, Oranienburg, I 4,[5],12:i:-, Javiana, Schwarzengrund, and Kentucky from broiler chicken farms and processing plants in Trinidad and Tobago. They also belonged to seven different sequence types (STs- 32, 292, 1510, 19, 24, 152, and 96). Among the strains, seven had demonstrated multi-drug resistance with the presence of at least three AMR genes, whereas three isolates contained the quinolone resistance gene qnr B19 in plasmids (CFSAN103840, CFSAN103854, and CFSAN103872). The extended-spectrum β-lactamase genes bla CTX-M-65 (CFSAN103796) and bla TEM-1 (CFSAN103852) were detected in this study. The genomes closed in this study will be useful for future source tracking and outbreak investigations in Trinidad and Tobago and worldwide.Entities:
Keywords: Salmonella; Trinidad and Tobago; complete genome; multi-drug resistance; nanopore sequencing; poultry
Year: 2022 PMID: 35620095 PMCID: PMC9127609 DOI: 10.3389/fmicb.2022.863104
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
Metadata for the eight Salmonella enterica strains isolated from chicken on poultry farms and processing plants were reported in this study.
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
|
|
| |||||||
| CFSAN103796 | CP066335 (4,727,835) | 52.3 | 95 | SRR11660184 (2,096,092) | SRR13073499 (47,009) |
| 32 | Infantis |
| CP066336 (312,952) | 50.3 | 83 |
| |||||
| CFSAN103854 | CP066333 (4,944,981) | 52.2 | 133 | SRR11660185 (2,482,592) | SRR13073498 (61,306) |
| 292 | Albany |
| CP066334 (3,071) | 48.2 | 33 |
| |||||
| CFSAN103872 | CP066260 (5,053,975) | 52.2 | 80 | SRR11660187 (1,533,662) | SRR13073497 (41,126) |
| 1510 | Oranienburg |
| CP066261 (49,044) | 49.3 | 265 |
| |||||
| CP066262 (5,320) | 52.4 | 400 | ||||||
| CFSAN103852 | CP066328 (4,836,001) | 52.2 | 129 | SRR12995791 (2,606,746) | SRR13073496 (70,597) |
| 19 | I 4,[5],12:i:- (Typhimurium) |
| CP066329 (110,489) | 50.2 | 189 |
| |||||
| CP066330 (93,844) | 53.1 | 228 | ||||||
| CP066331 (33,659) | 41.3 | 310 | ||||||
| CP066332 (1,749) | 57.5 | 1400 | ||||||
| CFSAN103840 | CP066325 (4,554,367) | 52.1 | 105 | SRR12995802 (2,110,046) | SRR13073495 (63,239) |
| 24 | Javiana |
| CP066326 (2,579) | 50.5 | 1000 |
| |||||
| CP066327 (1,395) | 55.2 | 3000 | ||||||
| CFSAN103816 | CP066324 (4,703,182) | 52.3 | 59 | SRR12995817 (2,060,084) | SRR13073494 (53,365) |
| 32 | Infantis |
| CFSAN103862 | CP066321 (4,847,947) | 52.2 | 125 | SRR12995807 (1,866,844) | SRR13073493 (106,256) |
| 96 | Schwarzengrund |
| CP066322 (144,839) | 49.0 | 198 |
| |||||
| CP066323 (4,050) | 42.8 | 700 | ||||||
| CFSAN103828 | CP066318 (4,767,999) | 52.2 | 30 | SRR12995770 (1,746,768) | SRR13073492 (30,574) |
| 152 | Kentucky |
| CP066319 (146,829) | 49.4 | 48 |
| |||||
| CP066320 (46,120) | 42.8 | 150 |
In silico antimicrobial genes were found using ResFinder-4.1 (
In silico MLST used the MLST website for Salmonella (
In silico serotyping using SeqSero (Zhang et al.,
Othmarschen by phenotypic method.
Figure 1Core genome multi-locus sequence type (cgMLST) analysis of the eight Salmonella closed genomes based on 4,028 shared genes. (A) NJ tree showing the genetic differences among these genomes based on the shared loci. (B) Minimum spanning tree allowing to visualize the number of loci differences between these genomes. Strains are color-coded according to their serotype (ST). The ST is displayed after the name of the strain, separated by a comma. Numbers by lines represent the number of loci differing between strains. The lines are not drawn to scale.
Comparison of blaCTX−M−65-positive plasmids from our study and four other US strains.
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
| ||||
| CFSAN103796 | 312,952 | IncFIB |
|
| CP066336 |
| 2014AM-3028 | 316,160 | IncFIB |
| CP016413 | |
| N55391 | 316,814 | IncFIB |
| CP016411 | |
| FSIS1502169 | 323,122 | IncFIB |
| CP016407 | |
| FSIS1502916 | 322,518 | IncFIB |
| CP016409 | |
Figure 2Comparison of blaCTX−M−65-positive plasmids from our study and four other US strains from Tate et al. (2017). Genetic map of the CFSAN103782 plasmid generated with CGView (25). The gray ring is the pCFSAN103796 plasmid. Blue block arrows in the outer circle denote coding regions in the plasmid indicating ORF transcription direction. The G+C content is shown in the middle circle and the deviation from the average G+C content in the innermost circle. BLAST comparisons with four other blaCTX-M-65-positive plasmids are shown in cyan (CP016413—strain 2014AM-3028), green (CP016411—strain N55391), yellow (CP016407—strain FSIS1502169), and pink (CP016409—strain FSIS1502916). The two sites containing the AMR genes mentioned in Table 2 are indicated.
Figure 3cgMLST analysis of six S. Infantis strains showing the divergent evolution of CFSAN103796 from the US strains (2014AM-3028, N55391, FSIS1502169, and FSIS1502916) and the other S. Infantis closed genome from Trinidad and Tobago (CFSAN103816). CFSAN103816 genome was used as an outgroup based on 3768 shared genes. (A) NJ tree showing the genetic differences among these genomes based on the shared loci rooted in CFSAN103816. (B) Minimum spanning tree allowing to visualize the number of loci differences between these genomes. Numbers by lines represent the number of loci differing between strains. The two S. Infantis from Trinidad and Tobago are shown in the colored boxes. The lines are not drawn to scale.
Phenotypic and plasmid classification per strain from this study.
|
|
|
| |
|---|---|---|---|
| CFSAN103796 | P (S), TE (R), CE (R), AM (R), PH (S), S (R), F (S) | IncFIB (CP066336) | |
| CFSAN103854 | P (S), TE (R), CE (S), AM (R), PH (S), S (S), F (S) | Col-pHAD28 (CP066334) | |
| CFSAN103872 | P (S), TE (R), CE (S), AM (R), PH (S), S (S), F (S) | IncN2 (CP066261) | |
| CFSAN103852 | P (R), TE (R), CE (S), AM (R), PH (S), S (S), F (S) | IncI1-I (CP066329), IncFIB/IncFII (CP066330), IncX1 (CP066331), ColpVC (CP066332) | |
| CFSAN103840 | P (S), TE (R), CE (S), AM (R), PH (S), S (S), F (S) | Col-pHAD28 (CP066326) | |
| CFSAN103816 | P (S), TE (S), CE (S), AM (R), PH (S), S (S), F (S) | NA | |
| CFSAN103862 | P (S), TE (R), CE (S), AM (R), PH (S), S (S), F (S) | IncFIB/IncFIC (CP066322) | |
| CFSAN103828 | P (S), TE (R), CE (S), AM (S), PH (S), S (S), F (S) | IncFIB/IncFII (CP066319), IncX1 (CP066320) |
P, penam (amoxicillin–clavulanic acid, 30 μg); TE, tetracycline (doxycycline, 30 μg); CE, cephalo-sporin (ceftriaxone, 30 μg); AM, aminoglycoside (gentamicin, 10 μg, and kanamycin, 30 μg); PH, phenicol (chloramphenicol, 30 μg); S, sulphonamide (sulfamethoxazole–trimethoprim, 23.75 and 1.25 μg); F, fluoroquinolone (ciprofloxacin, 5 μg).
Incompatibility group replicon.
For the complete list, please go to .